Comparing Ibrance vs Xeloda
| Ibrance | Xeloda |
|
|---|
| Ibrance (palbociclib) | Xeloda (capecitabine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ibrance is a CDK4/6 inhibitor that may be used to treat advanced or metastatic hormone-receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer in combination... View more |
Prescription only
Prescribed for Colorectal Cancer, Breast Cancer - Metastatic, Breast Cancer. Xeloda may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
Breast Cancer, Metastatic
|
|||||||||||||||
| More about Ibrance (palbociclib) | More about Xeloda (capecitabine) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Ibrance has an average rating of 6.6 out of 10 from a total of 70 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 32% reported a negative effect. |
Xeloda has an average rating of 6.7 out of 10 from a total of 30 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Common side effects include:
See also: Ibrance side effects in more detail. |
Common side effects include:
See also: Xeloda side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ibrance prices |
View all Xeloda prices and generic prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
29 hours |
0.75 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 421 drugs are known to interact with Ibrance:
|
A total of 243 drugs are known to interact with Xeloda:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 03, 2015 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.